AstraZeneca PLC
27 February 2007
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rules DR 3.1.2R
We hereby inform you that on 23 February 2007, the following individuals, who
are all persons discharging managerial responsibilities, acquired an interest in
the USD0.25 Ordinary Shares of AstraZeneca PLC or, in the case of A Zook, over
the Company's American Depositary Shares (ADSs). One ADS equals one Ordinary
Share. The interest arises as a result of the previously disclosed arrangements
relating to the payment of annual bonuses for 2006 whereby each individual is
required to defer a portion of the bonus earned into shares for a period of
three years. The shares are awarded under the terms of the AstraZeneca Deferred
Bonus Plan. The individuals will become beneficially entitled to these shares
on 23 February 2010.
Number of shares Award price per
Name allocated share
B Angelici 1,984 2911p
A Bloxham 1,366 2911p
J Lundberg 1,762 2911p
M Nicklasson 1,803 2911p
D Smith 982 2911p
A Zook 1,755 US$57.19
G H R Musker
Company Secretary
27 February 2007
This information is provided by RNS
The company news service from the London Stock Exchange UBUNRBRRUUAR
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.